- Home
- HLLY vs KROS Comparison
HLLY vs KROS Comparison
Compare HLLY & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HLLY | KROS |
|---|---|---|
| Founded | 1903 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.6M | 222.7M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HLLY | KROS |
|---|---|---|
| Price | $2.48 | $11.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $4.58 | ★ $19.83 |
| AVG Volume (30 Days) | ★ 1.0M | 161.7K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 180.00 | 146.00 |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $613,514,000.00 | $243,864,000.00 |
| Revenue This Year | $1.84 | N/A |
| Revenue Next Year | $4.33 | N/A |
| P/E Ratio | $64.63 | ★ N/A |
| Revenue Growth | ★ 1.87 | N/A |
| 52 Week Low | $2.25 | $9.69 |
| 52 Week High | $4.48 | $22.55 |
Technical Indicators
Market Signals| Indicator | HLLY | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 49.12 |
| Support Level | $2.37 | $10.85 |
| Resistance Level | $2.66 | $11.86 |
| Average True Range (ATR) | 0.13 | 0.53 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 47.19 | 34.36 |
Price Performance
Historical ComparisonAbout HLLY Holley Inc.
Holley Inc designs, manufactures, and distributes high-performance automotive aftermarket products to car and truck enthusiasts in the United States, Canada and Europe. It manufactures a diversified line of performance automotive products, including carburetors, fuel pumps, fuel injection systems, nitrous oxide injection systems, superchargers, exhaust headers, mufflers, distributors, ignition components, engine tuners and automotive performance plumbing products. It also manufactures exhaust products as well as shifters, converters, transmission kits, transmissions, tuners and automotive software. The company markets its products under brands such as Holley, Holley EFI, MSD, Simpson, Flowmaster, EDGE, Cataclean, and Accel, among others. It operates in single segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.